ArticleBMC health services research2024
Stakeholder analysis of banning unhealthy product advertisement in Iran.
Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe advertising of unhealthy products, including unhealthy foods, drugs with abuse potential, certain cosmetic products and services, and tobacco, has raised significant public health concerns due to its role in increasing consumption and contributing to the rise of non-communicable diseases. Policy development and enforcement in this area necessitate an in-depth analysis of the relevant stakeholders. This study aims to examine the stakeholders involved in regulating the advertisement of unhealthy products in Iran, providing critical evidence for shaping advertising regulations and reducing the societal consumption of such products.
methodsThis qualitative study, conducted in 2022, involved 18 experts experienced in the area of unhealthy product advertisement in Iran. Participants were selected through purposive and snowball sampling methods. The stakeholders' roles, power, positions, and interests were analyzed using Schmeer's guidelines.
results17 stakeholders were identified as relevant to the ban on unhealthy product advertisements, of whom 14 were classified as active and three as inactive. Key stakeholders included radio and television broadcasters, the Ministries of Health, Culture, and Industry, as well as political institutions. The Ministry of Health (MOHME) emerged as a leading advocate for the ban, while the Ministries of Culture and Industry, along with political institutions, were identified as possessing significant power with moderate support for the policy. In contrast, broadcasters and social media platforms were powerful opponents of the ban.
conclusionsThe study underscores the pivotal role of stakeholders with high power and medium interest in the success of policies aimed at banning unhealthy product advertisements. Key challenges included conflicts of interest, insufficient penalties for organizations violating advertising regulations, organizational disputes, limited human and financial resources, lack of clear implementation guidelines, weak community engagement, and inadequate oversight. Engaging key stakeholders effectively could mitigate these obstacles and facilitate more effective health policy interventions in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.